These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2578913)

  • 1. Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Clin Sci (Lond); 1985 Mar; 68(3):369-71. PubMed ID: 2578913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Br J Urol; 1984 Dec; 56(6):594-8. PubMed ID: 6085478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects].
    Fukatani T
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):246-53. PubMed ID: 1710303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium pentosan polysulphate--a novel inhibitor of urinary risk factors and enzymes in experimental urolithiatic rats.
    Senthil D; Malini MM; Varalakshmi P
    Ren Fail; 1998 Jul; 20(4):573-80. PubMed ID: 9713875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.
    Martin X; Werness PG; Bergert JH; Smith LH
    J Urol; 1984 Oct; 132(4):786-8. PubMed ID: 6206244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.
    Senthil D; Subha K; Saravanan N; Varalakshmi P
    Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of factors affecting calcium oxalate crystalline aggregation.
    Grases F; Costa-Bauzá A
    Br J Urol; 1990 Sep; 66(3):240-4. PubMed ID: 1698500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of sodium pentosan polysulfate on the formation, growth and aggregation of calcium oxalate in vitro].
    Suzuki K; Miyazawa K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):526-31. PubMed ID: 2473238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of two new semi-synthetic glycosaminoglycans (G871, G872) on the zeta potential of calcium oxalate crystals and on growth and agglomeration.
    Cao LC; Boevé ER; Schröder FH; Robertson WG; Ketelaars GA; de Bruijn WC
    J Urol; 1992 Jun; 147(6):1643-6. PubMed ID: 1593714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of two new polysaccharides on growth, agglomeration and zeta potential of calcium phosphate crystals.
    Boevé ER; Cao LC; Deng G; De Bruijn WC; Schröder FH
    J Urol; 1996 Jan; 155(1):368-73. PubMed ID: 7490888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.
    Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL
    Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does urinary oxalate interfere with the inhibitory role of glycosaminoglycans and semisynthetic sulfated polysaccharides in calcium oxalate crystallization?
    Cao LC; Deng G; Boevé ER; Romijn JC; de Bruijn WC; Verkoelen CF; Schröder FH
    Eur Urol; 1997; 31(4):485-92. PubMed ID: 9187912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth.
    Fellström B; Danielson BG; Ljunghall S; Wikström B
    Clin Chim Acta; 1986 Aug; 158(3):229-35. PubMed ID: 2429785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glycoproteins in calcium oxalate crystal development.
    Grases F; Isern B; Perelló J; Costa-Bauzá A
    BJU Int; 2004 Jul; 94(1):177-81. PubMed ID: 15217456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The quantitative study of inhibitory effect of pentosan polysulfate and chlorophyllin on the experimental calcium oxalate stone].
    Miyazawa K; Suzuki K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):861-9. PubMed ID: 2477580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum lipids and lipoproteins in calcium oxalate stone forming rats treated with sodium pentosan polysulphate.
    Subha K; Sivamurugesan A; Varalakshmi P
    Biochem Int; 1992 Sep; 27(6):1011-8. PubMed ID: 1280138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of glycosaminoglycans induced in newly formed calcium oxalate crystals using an undiluted urine system.
    Suzuki K; Tsugawa R
    Scanning Microsc; 1995; 9(4):1089-95; discussion 1095-6. PubMed ID: 8819890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones?
    Jones M; Monga M
    J Endourol; 2003 Dec; 17(10):855-8. PubMed ID: 14744348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium pentosan polysulphate on tissue lipids in control and glycollate treated rats.
    Subha K; Varalakshmi P
    Pharmacol Res; 1993; 27(4):289-97. PubMed ID: 7690133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.